Key players in Axial Spondyloarthritis (axSpA)
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  AbbVie Inc. |
abbvie.com (opens in a new tab) | 1,254 reports |
| 2 |  Eli Lilly and Company |
lilly.com (opens in a new tab) | 1,056 reports |
| 3 |  Johnson & Johnson |
jnj.com (opens in a new tab) | 2,376 reports |
| 4 |  Novartis AG |
novartis.com (opens in a new tab) | 1,551 reports |
| 5 |  Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
| 6 | UCB | — | 231 reports |
| 7 |  Amgen Inc. |
amgen.com (opens in a new tab) | 693 reports |
Also active in Axial Spondyloarthritis (axSpA)
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 Amneal Pharmaceuticals, Inc |
|
| Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. |
|
 Hikma Pharmaceuticals PLC |
|
 Aurobindo Pharma |
|
| UCB Biopharma SRL |
|
| Biocad |
|
| Novitium Pharma | |
| Care Arthritis Ltd. |
|
| Zydus Lifesciences | |
| PH Health | |
| Watson Laboratories | |
 Fresenius SE & CO |
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Top trial sponsors in Axial Spondyloarthritis (axSpA)
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Novartis AG 3 active trials on ClinicalTrials.gov (opens in a new tab)
- UCB Biopharma SRL 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Biocad 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Care Arthritis Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Axial Spondyloarthritis (axSpA) reports by place
One report for each place. Each tile opens that place's report.
Regions 7
Countries 26
Australia report
Brazil report
Canada report
China report
Ecuador report
Egypt report
France report
Germany report
Hong Kong report
India report
Italy report
Japan report
Kenya report
Malaysia report
Mexico report
New Zealand report
Philippines report
Russia report
Saudi Arabia report
Singapore report
South Africa report
Spain report
Thailand report
UAE report
UK report
US report
Compare all 33 places for Axial Spondyloarthritis (axSpA), with active trials
Get the full Axial Spondyloarthritis (axSpA) report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.